Literature DB >> 21453618

Aplastic anemia: clinicohaematological features, treatment and outcome analysis.

Rabia Wali1, Zehra Fadoo, Salman Adil, Muhammad Ahmed Naqvi.   

Abstract

OBJECTIVE: To determine the clinicohaematological features, treatment and outcome of children diagnosed with aplastic anemia at a single institution. STUDY
DESIGN: Observational study. PLACE AND DURATION OF STUDY: The Aga Khan University Hospital, Karachi, from January 1999 till December 2008.
METHODOLOGY: Medical records of children aged less than 15 years of age diagnosed with aplastic anemia were reviewed. Clinicohaematological features, treatment and its response to therapy and outcome were recorded. Results were described in percentages.
RESULTS: Ninety patients were diagnosed to have aplastic anemia (AA); 65 were male during the study period. Age ranged from 1 to 15 years. Fever in 65 patients (72.2%), pallor in 53 (58.8%), skin bleeding in 49 (54.4%) and epistaxis in 31(34.4%) were the most common and frequent presenting features. Congenital (Fanconi's) anemia was found in 15 (16.6%) and acquired idiopathic in 75 (83.4%) of patients. Very severe aplastic anemia (VSAA) was seen in 29 (32.2%), 26 (28.9%) had severe AA and 17 (18.9%) had moderate AA. Eight patients (8.9%) underwent haematopoietic stem cell transplantation (HSCT), 12 (13.3%) received immunosuppressive therapy (IST) and 70 patients (77.7%) received other and supportive therapy. Five (62.5%) patients showed complete response to HSCT and 3 (37.5%) failed to engraft. IST showed complete response in 3 (25%), partial response in 5 (41.6%) and no response in 4 (33.3%). Twenty two patients (24.4%) expired either due to infection in 16 (72.7%, fungal in 6, bacterial in 10) and intracranial haemorrhage in 6 (27.3%) cases.
CONCLUSION: Majority of cases with AA were acquired and idiopathic in etiology. VSAA and SAA were frequent. Response to HSCT and IST was sub-optimal.

Entities:  

Mesh:

Year:  2011        PMID: 21453618     DOI: 04.2011/JCPSP.219222

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  3 in total

1.  Expression of IL-27, Th1 and Th17 in patients with aplastic anemia.

Authors:  Hui-zhen Du; Qian Wang; Jian Ji; Bao-ming Shen; Shao-chun Wei; Li-juan Liu; Juan Ding; Dao-xin Ma; Wen Wang; Jun Peng; Ming Hou
Journal:  J Clin Immunol       Date:  2012-09-30       Impact factor: 8.317

2.  Should we still use Camitta's criteria for severe aplastic anemia?

Authors:  Hyun Hwa Yoon; Seok Jae Huh; Ji Hyun Lee; Suee Lee; Sung-Hyun Kim; Hyuk Chan Kwon; Hyo-Jin Kim
Journal:  Korean J Hematol       Date:  2012-06-26

3.  Extra-Axial Hematoma and Trimethoprim-Sulfamethoxazole Induced Aplastic Anemia: The Role of Hematological Diseases in Subdural and Epidural Hemorrhage.

Authors:  Richard P Menger; Rimal H Dossani; Jai Deep Thakur; Frank Farokhi; Kevin Morrow; Bharat Guthikonda
Journal:  Case Rep Hematol       Date:  2015-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.